ST3-H2A2 is known to be a highly selective inhibitor of STAT3 ND that binds to the N-terminal domain (ND) and inhibits STAT3 signaling without affecting expression of STAT3 and pSTAT3 in cancer cell lines26. Here, STAT3 is linked to cancer.